About: Leveraging Tele-Critical Care Capabilities for Clinical Trial Consent

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Leveraging Tele-Critical Care Capabilities for Clinical Trial Consent Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Leveraging Tele-Critical Care Capabilities for Clinical Trial Consent
Creator	Michael, ; Cain, Janell Colombo, Christopher Colombo, Rhonda Deacy, Thomas Ieronimakis, Kristina Odineal, David Switzer, Michael Stein, T
Source	Medline; PMC
abstract	A severe coronavirus disease 2019 patient admitted to our institution for medical management was enrolled in a randomized placebo-controlled trial of an investigational therapeutic for coronavirus disease 2019. We leveraged existing video-telecommunication equipment to obtain informed consent. We found video-telecommunication use closely mirrored person-to-person contact for research consent by maintaining engagement and ensuring understanding. Video-telecommunication use facilitated clinical research while minimizing unnecessary exposure to coronavirus disease 2019 and conserving personal protective equipment. Prior to the coronavirus disease 2019 pandemic, research regulatory agencies were essentially silent on the matter of video-telecommunication consent. Regulatory guidance became available during the pandemic in response to increased isolation and social distancing practices. Virtual health and telemedicine use expanded greatly during the pandemic, and this increase will likely persist after the pandemic ends. We anticipate video-telecommunication adoption and implementation for research consent will also continue to grow after the coronavirus disease 2019 pandemic is over.
has issue date	2020-06-25(xsd:dateTime)
bibo:doi	10.1097/cce.0000000000000167
bibo:pmid	32766563
has license	no-cc
sha1sum (hex)	4ed5cdc4f97d93f2940dda042345a069ed2bcc5e
schema:url	https://doi.org/10.1097/cce.0000000000000167
resource representing a document's title	Leveraging Tele-Critical Care Capabilities for Clinical Trial Consent
has PubMed Central identifier	PMC7339318
has PubMed identifier	32766563
schema:publication	Crit Care Explor
resource representing a document's body	covid:4ed5cdc4f97d93f2940dda042345a069ed2bcc5e#body_text
is schema:about of	named entity 'placebo-controlled trial' named entity 'response' named entity 'expanded' named entity 'patient' named entity 'Regulatory' named entity 'PERSONAL PROTECTIVE EQUIPMENT' named entity 'MEDICAL MANAGEMENT' named entity 'PERSON' named entity 'TELECOMMUNICATION' named entity 'MIRRORED' named entity 'RANDOMIZED PLACEBO-CONTROLLED TRIAL' named entity 'PRIOR TO' named entity 'EQUIPMENT' named entity 'INSTITUTION' named entity 'ENGAGEMENT' named entity 'MAINTAINING' named entity 'INCREASE' named entity 'adoption' named entity 'randomized' named entity 'pandemic' named entity 'institution' named entity 'investigational' named entity 'medical management' named entity 'existing' named entity 'coronavirus disease 2019' named entity 'telecommunication' named entity 'regulatory agencies' named entity 'telemedicine' named entity 'coronavirus disease 2019' named entity 'coronavirus disease 2019' named entity 'informed consent' named entity 'Clinical Trial' named entity 'Critical Care' named entity 'Principal Investigator' named entity 'research team' named entity 'Healthcare providers' named entity 'Critical Care' named entity 'placebo-controlled trial' named entity 'IRB' named entity 'informed consent' named entity 'smartphone' named entity 'CRC' named entity 'telemedicine' named entity 'COVID-19' named entity 'informed consent' named entity 'social distancing' named entity 'mobile devices' named entity 'long-term' named entity 'high definition' named entity 'FDA' named entity 'infection control' named entity 'informed consent' named entity 'Food and Drug Administration' named entity 'investigational therapy' named entity 'telephone' named entity 'self-quarantine' named entity 'research team' named entity 'COVID-19' named entity 'COVID-19' named entity 'public health' named entity 'informed consent' named entity 'Madigan Army Medical Center' named entity 'FDA' named entity 'clinical equipoise' named entity 'PPE' named entity 'COVID-19' named entity 'telehealth' named entity 'patient-centered care' named entity 'COVID-19' named entity 'COVID-19 pandemic' named entity 'Human Research Protections' named entity 'coronavirus disease 2019' named entity 'follow-up'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software